Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study Assessing Evaluation of the Interest of Serum S100B Protein Determination in the Management of Pediatric Mild Traumatic Brain Injury
Sponsor: University Hospital, Clermont-Ferrand
Summary
Mild traumatic brain injury (mTBI) is a very common reason for presentation to pediatric emergency departments. So as not to overlook the risk of complications, which occur at a rate of 0-7%, measures such as cranial computed tomography (CCT-scan) and/or short inpatient observation are prescribed. Ultimately, the majority of these measures could be avoided and a large Australian cohort shows that the risk of brain tumors is 2.44 times higher for children who had a CCT-scan (3.24 for age 1-4 years). Assay of a sensitive biomarker in blood, such as the S100B protein, has the potential to reduce the number of these unnecessary measures.
Official title: Interventional Study Assessing Evaluation of the Interest of Serum S100B Protein Determination in the Management of Pediatric Mild Traumatic Brain Injury
Key Details
Gender
All
Age Range
0 Years - 16 Years
Study Type
INTERVENTIONAL
Enrollment
2209
Start Date
2016-11-02
Completion Date
2022-05-31
Last Updated
2026-04-21
Healthy Volunteers
No
Conditions
Interventions
usual care
S100B
Locations (11)
Hospices Civils de LYON
Bron, France
CHU Clermont-Ferrand
Clermont-Ferrand, France
Limoges Teaching hospital
Limoges, France
Assistance Publique des Hôpitaux de Marseille
Marseille, France
Montpellier Teaching hopsital
Montpellier, France
Nantes Teaching Hospital
Nantes, France
Nice Teaching Hospital
Nice, France
Nimes Teaching Hospital
Nîmes, France
Reims Teaching Hospital
Reims, France
Saint-Etienne Teaching Hospital
Saint-Etienne, France
Vichy Hospital Center
Vichy, France